Lipocine Inc. (LPCN) Form 10-K Annual Reports
Lipocine Inc. (LPCN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LPCN
CIK: 1535955
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Tanner LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerReed Chase
Audit LocationSalt Lake City, Utah, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-07 | 2026-10-07 | 8-K | 0001493152-26-046060 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-29 | 4 | 0001493152-26-045400 | View SEC Doc Filr Page |
| 4 | 2026-09-30 | 2026-09-28 | 4 | 0001493152-26-045185 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-16 | 8-K | 0001493152-26-042933 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-14 | 8-K | 0001493152-26-042466 | View SEC Doc Filr Page |
| 8-K | 2026-09-11 | 2026-09-08 | 8-K | 0001493152-26-042286 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-10 | 8-K | 0001493152-26-042052 | View SEC Doc Filr Page |
| 8-K/A | 2026-08-21 | 2026-08-03 | 8-K/A | 0001493152-26-039689 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0002050709-26-000023 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-03 | 4 | 0001493152-26-036577 | View SEC Doc Filr Page |
| 3 | 2026-08-07 | 2026-08-03 | 3 | 0001493152-26-036573 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001493152-26-035913 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0001493152-26-035909 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001493152-26-035762 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-29 | 4 | 0001493152-26-031377 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-12 | 8-K | 0001493152-26-028429 | View SEC Doc Filr Page |
| S-8 | 2026-06-09 | — | S-8 | 0001493152-26-027923 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-03 | 8-K | 0001493152-26-027266 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | 4 | 0001493152-26-027262 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | 4 | 0001493152-26-027261 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | 4 Filing | 0001493152-26-027259 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-04 | 8-K | 0001493152-26-027209 | View SEC Doc Filr Page |
| 8-K | 2026-05-26 | 2026-05-26 | 8-K | 0001493152-26-025270 | View SEC Doc Filr Page |
| 8-K | 2026-05-19 | 2026-05-19 | 8-K | 0001493152-26-024365 | View SEC Doc Filr Page |
| 8-K | 2026-05-18 | 2026-05-18 | 8-K | 0001493152-26-024097 | View SEC Doc Filr Page |